ClinicalTrials.gov - PCO-02 - Safety and Pharmacokinetics Trial (NCT02637284): Specific details of the Phase 1 trial
The typical form of B12 used in doctors offices is cyanocobalamin, a cheaper and subpar form of B12
Muscles Ligaments Tend J 5(2):9298 Niering M, Muehlbauer T (2021) Effects of physical training on physical and psychological parameters in individuals with patella tendinopathy: a systematic review and meta-analysis
doi:10.1007/s00270-022-03199-8
Our BPC-157 TB-500 blend is manufactured according to strict quality-control standards designed to support consistency, purity, and reliability across laboratory research applications
Corticosteroids : Potentially protective : May counteract steroid-induced muscle wasting Theoretical Interactions (Use Caution): Dopamine medications (Parkinson's drugs): Possible interference, BPC-157 modulates dopamine pathways Blood pressure medications : Synergistic or antagonistic effects, both affect vascular tone Anticoagulants (blood thinners): Unknown bleeding risk, BPC-157 affects blood vessel formation Immunosuppressants : Unknown, may interact with healing mechanisms Practical Guidance: 1.Consult your healthcare provider before starting BPC-157 2.Space peptide doses at least 4 hours from medications 3.Start with lower BPC-157 doses (100-200 mcg) 4.Monitor for unusual changes in medication effects Long-Term Safety: What We Know and Don't Know Most BPC-157 studies last 2-6 weeks